Lysosomal exoglycosidases as biomarkers of systemic diseases – what’s new?
Numerous studies suggest that lysosomal exoglycosidases can be utilised in the diagnosis and monitoring of various diseases. This paper summarises recent reports on the clinical use of N-acetyl-β-D-hexosaminidase (HEX), β-glucuronidase (GLU), β-galactosidase (GAL), α-mannosidase (MAN) and α-L-fucosidase (FUC) in system...